Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
The Journal of Biological Chemistry
|
August 25, 1972
Human fibrinogen heterogeneities. II. Cross-linking capacity of high solubility catabolic intermediates
J S Finlayson, M W Mosesson, T J Bronzert, et al.
The Journal of Clinical Investigation
|
September 1, 1971
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release
H R Gralnick, H M Givelber, J R Shainoff, et al.
Annals of the New York Academy of Sciences
|
December 8, 1972
Epsilon-(gamma-glutamyl) lysine cross-links: determination in fibrin from normal and factor XIII-deficient individuals
J J Pisano, T J Bronzert, M P Peyton, et al.
Transfusion
|
January 27, 1999
Hemolysis and acute renal failure due to the administration of albumin diluted in sterile water
L R Pierce, A Gaines, J S Finlayson, et al.
Archives of Biochemistry and Biophysics
|
August 1, 1982
Rabbit fibrinogen: time course of constituent chain production in vivo
B M Alving, S I Chung, G Murano, et al.
The Journal of Clinical Investigation
|
December 1, 1977
Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma
D L Aronson, L Stevan, A P Ball, et al.
Transfusion
|
September 1, 1995
Fibrin sealant: summary of a conference on characteristics and clinical uses
B M Alving, M J Weinstein, J S Finlayson, et al.
Biology of Reproduction
|
September 1, 1976
Chromatographic separation of puberty accelerating pheromone from male mouse urine
J G Vandenbergh, J S Finlayson, W J Dobrogosz, et al.
Transfusion
|
September 1, 1996
Considerations of pool size in the manufacture of plasma derivatives
T J Lynch, M J Weinstein, D L Tankersley, et al.
Thrombosis Research
|
September 1, 1978
Congenital dysfibrinogenemia: fibrinogen Lille
M H Denninger, J S Finlayson, L A Reamer, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
The Journal of Biological Chemistry
|
August 25, 1972
Human fibrinogen heterogeneities. II. Cross-linking capacity of high solubility catabolic intermediates
J S Finlayson, M W Mosesson, T J Bronzert, et al.
The Journal of Clinical Investigation
|
September 1, 1971
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release
H R Gralnick, H M Givelber, J R Shainoff, et al.
Annals of the New York Academy of Sciences
|
December 8, 1972
Epsilon-(gamma-glutamyl) lysine cross-links: determination in fibrin from normal and factor XIII-deficient individuals
J J Pisano, T J Bronzert, M P Peyton, et al.
Transfusion
|
January 27, 1999
Hemolysis and acute renal failure due to the administration of albumin diluted in sterile water
L R Pierce, A Gaines, J S Finlayson, et al.
Archives of Biochemistry and Biophysics
|
August 1, 1982
Rabbit fibrinogen: time course of constituent chain production in vivo
B M Alving, S I Chung, G Murano, et al.
The Journal of Clinical Investigation
|
December 1, 1977
Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma
D L Aronson, L Stevan, A P Ball, et al.
Transfusion
|
September 1, 1995
Fibrin sealant: summary of a conference on characteristics and clinical uses
B M Alving, M J Weinstein, J S Finlayson, et al.
Biology of Reproduction
|
September 1, 1976
Chromatographic separation of puberty accelerating pheromone from male mouse urine
J G Vandenbergh, J S Finlayson, W J Dobrogosz, et al.
Transfusion
|
September 1, 1996
Considerations of pool size in the manufacture of plasma derivatives
T J Lynch, M J Weinstein, D L Tankersley, et al.
Thrombosis Research
|
September 1, 1978
Congenital dysfibrinogenemia: fibrinogen Lille
M H Denninger, J S Finlayson, L A Reamer, et al.
Page
of 7